Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose Aripiprazole
Clinical Psychopharmacology and Neuroscience
;
: 221-225, 2016.
Article
in English
| WPRIM
| ID: wpr-175039
ABSTRACT
The present report describes the cases of a 17-year-old male patient and a 13-year-old female patient who developed acute dystonia following the administration of low-dose aripiprazole (5 mg/day) after the cessation of atomoxetine treatment. Although aripiprazole-induced dystonia has been previously reported in the literature, it is rare, and most of these cases were associated with doses higher than 5 mg/day. Furthermore, both of the patients in the present study discontinued atomoxetine prior to the initiation of aripiprazole treatment; thus, this report also discussed the possible mechanisms underlying the manifestation of dystonia from the perspective of neurotransmitter activity.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Neurotransmitter Agents
/
Dystonia
Limits:
Adolescent
/
Female
/
Humans
/
Male
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS